23
Part I: Introduction to SHARPn Normalization Hongfang Liu, PhD, Mayo Clinic Tom Oniki, PhD, Intermountain Healthcare

Part I: Introduction to SHARPn Normalization Hongfang Liu, PhD, Mayo Clinic Tom Oniki, PhD, Intermountain Healthcare

Embed Size (px)

DESCRIPTION

Data Normalization  Information Models Target Value Sets Raw EMR Data Tooling Normalized EMR Data Normalization Targets Normalization Process

Citation preview

Page 1: Part I: Introduction to SHARPn Normalization Hongfang Liu, PhD, Mayo Clinic Tom Oniki, PhD, Intermountain Healthcare

Part I: Introduction toSHARPn Normalization

Hongfang Liu, PhD, Mayo ClinicTom Oniki, PhD, Intermountain Healthcare

Page 2: Part I: Introduction to SHARPn Normalization Hongfang Liu, PhD, Mayo Clinic Tom Oniki, PhD, Intermountain Healthcare

Data Normalization

Goals– To conduct the science for realizing semantic

interoperability and integration of diverse data sources

– To develop tools and resources enabling the generation of normalized EMR data for secondary uses

Page 3: Part I: Introduction to SHARPn Normalization Hongfang Liu, PhD, Mayo Clinic Tom Oniki, PhD, Intermountain Healthcare

Data Normalization

Information Models

Target Value Sets

Raw EMR Data

Tooling

Normalized EMR Data

Normalization Targets

Normalization Process

Page 4: Part I: Introduction to SHARPn Normalization Hongfang Liu, PhD, Mayo Clinic Tom Oniki, PhD, Intermountain Healthcare

Normalization Targets

Clinical Element Models– Intermountain Healthcare/GE Healthcare’s

detailed clinical modelsTerminology/value sets associated with

the models– using standards where possible

Page 5: Part I: Introduction to SHARPn Normalization Hongfang Liu, PhD, Mayo Clinic Tom Oniki, PhD, Intermountain Healthcare

CEM Models

Different models for different use cases“CORE” models

Page 6: Part I: Introduction to SHARPn Normalization Hongfang Liu, PhD, Mayo Clinic Tom Oniki, PhD, Intermountain Healthcare

“Core” Models

CORELab CEM modelattribute 1

attribute 2

attribute 3

attribute 4

CEM A

CEM C

CEM B

CEM D

Page 7: Part I: Introduction to SHARPn Normalization Hongfang Liu, PhD, Mayo Clinic Tom Oniki, PhD, Intermountain Healthcare

“Core” Models

CORELab CEM modelattribute 1

attribute 2

attribute 3

attribute 4

Secondary Use Lab CEM model

CEM A

CEM C

CEM B

CEM D

attribute 1

attribute 2

attribute 3

attribute 4

CEM A

CEM C

CEM B

CEM D

Page 8: Part I: Introduction to SHARPn Normalization Hongfang Liu, PhD, Mayo Clinic Tom Oniki, PhD, Intermountain Healthcare

“Core” Models

CORELab CEM modelattribute 1

attribute 2

attribute 3

attribute 4

Secondary Use Lab CEM model

CEM A

CEMC

CEM B

CEMD

attribute 1

attribute 2

attribute 3

attribute 4

Clinical TrialLab CEM model

CEMA

CEM C

CEM B

CEM D

attribute 1

attribute 2

attribute 3

attribute 4CEM A

CEM C

CEM B

CEM D

Page 9: Part I: Introduction to SHARPn Normalization Hongfang Liu, PhD, Mayo Clinic Tom Oniki, PhD, Intermountain Healthcare

“Core” Models

CORELab CEM modelattribute 1

attribute 2

attribute 3

attribute 4

Secondary Use Lab CEM model

CEM A

CEMC

CEM B

CEMD

attribute 1

attribute 2

attribute 3

attribute 4

Clinical TrialLab CEM model

CEM A

CEM C

CEM B

CEM D

attribute 1

attribute 2

attribute 3

attribute 4CEM A

CEM C

CEM B

CEM D

EMRLab CEM model

CEM A

CEM C

CEM B

CEM D

attribute 1

attribute 2

attribute 3

attribute 4

Page 10: Part I: Introduction to SHARPn Normalization Hongfang Liu, PhD, Mayo Clinic Tom Oniki, PhD, Intermountain Healthcare

CEM Models

Different models for different use cases“CORE” models

– CORENotedDrug -> SecondaryUseNotedDrug

– COREStandardLab -> SecondaryUseStandardLab (+ 6 data type-specific models)

– COREPatient -> SecondaryUsePatient

Page 11: Part I: Introduction to SHARPn Normalization Hongfang Liu, PhD, Mayo Clinic Tom Oniki, PhD, Intermountain Healthcare

Generating XSDsSecondary Use Lab CEM model

CEM A

CEM C

CEM B

CEM D

attribute 1

attribute 2

attribute 3

attribute 4

Page 12: Part I: Introduction to SHARPn Normalization Hongfang Liu, PhD, Mayo Clinic Tom Oniki, PhD, Intermountain Healthcare

Generating XSDsSecondary Use Lab CEM model

CEM A

CEM C

CEM B

CEM D

attribute 1

attribute 2

attribute 3

attribute 4

SHARP“reference class”

attribute 5

attribute 6

attribute 7

attribute 8

CEM E

CEM G

CEM F

CEM H

Page 13: Part I: Introduction to SHARPn Normalization Hongfang Liu, PhD, Mayo Clinic Tom Oniki, PhD, Intermountain Healthcare

Generating XSDsSecondary Use Lab CEM model

CEM A

CEM C

CEM B

CEM D

attribute 1

attribute 2

attribute 3

attribute 4

SHARP“reference class”

attribute 5

attribute 6

attribute 7

attribute 8

CEM E

CEM G

CEM F

CEM H

COMPILE

Secondary Use Lab XSDattribute 1. . . . . . . . .attribute 3. . . . . . . . .attribute 5. . . . . . . . .attribute 6. . . . . . . . .attribute 7. . . . . . . . .attribute 8. . . . . . . . .

Page 14: Part I: Introduction to SHARPn Normalization Hongfang Liu, PhD, Mayo Clinic Tom Oniki, PhD, Intermountain Healthcare

Terminology/Value SetsTerminology value sets define the valid values used

in the modelsTerminology standards are used wherever possible

Page 15: Part I: Introduction to SHARPn Normalization Hongfang Liu, PhD, Mayo Clinic Tom Oniki, PhD, Intermountain Healthcare

Terminology/Value SetsTerminology value sets define the valid values used

in the modelsTerminology standards are used wherever possible

Secondary UsePatient CEM model

CEM B

CEM A

CEM C

administrativeGender

attribute X

attribute Y

attribute Z

Gender CEM GenderValue Set:

HL7AdminGender

{M, F}

Page 16: Part I: Introduction to SHARPn Normalization Hongfang Liu, PhD, Mayo Clinic Tom Oniki, PhD, Intermountain Healthcare

CEM Request Site and Browser

https://intermountainhealthcare.org/CEMrequests

Page 17: Part I: Introduction to SHARPn Normalization Hongfang Liu, PhD, Mayo Clinic Tom Oniki, PhD, Intermountain Healthcare

Normalization Process

Prepare Mapping UIMA Pipeline to transform raw EMR data

to normalized EMR data based on mappings

Page 18: Part I: Introduction to SHARPn Normalization Hongfang Liu, PhD, Mayo Clinic Tom Oniki, PhD, Intermountain Healthcare

Mappings

Two kinds of mappings needed:– Model Mappings– Terminology Mappings

Page 19: Part I: Introduction to SHARPn Normalization Hongfang Liu, PhD, Mayo Clinic Tom Oniki, PhD, Intermountain Healthcare

Model MappingsHL7 CEM

Secondary Use Patient CEM model

CEM A

CEM C

CEM B

CEM D

attribute 1

attribute 2

attribute 3

attribute 4

MSHPID

12…

OBROBX

123456…

Secondary Use Lab CEM model

CEM A

CEM C

CEM B

CEM D

attribute 1

attribute 2

attribute 3

attribute 4

Page 20: Part I: Introduction to SHARPn Normalization Hongfang Liu, PhD, Mayo Clinic Tom Oniki, PhD, Intermountain Healthcare

Model Mappings

Page 21: Part I: Introduction to SHARPn Normalization Hongfang Liu, PhD, Mayo Clinic Tom Oniki, PhD, Intermountain Healthcare

Terminology Mappings

HL7 from Mayo CEM

Local Gender Codes1 = MALE2 = FEMALE

HL7 AdministrativeGenderM = MALEF = FEMALE

Page 22: Part I: Introduction to SHARPn Normalization Hongfang Liu, PhD, Mayo Clinic Tom Oniki, PhD, Intermountain Healthcare

Terminology MappingsCEM Fields LocalCode TargetCode TargetCodeSystemGender M M HL7 GenderGender F F HL7 GenderRace 2 2106-3 CDC RaceRace W 2106-3 CDC RaceRouterMethodDevice ORAL PO HL7 Route DoseFreq BID &0800,173 229799001 SNOMED DoseFreq BID &0800,220 229799001 SNOMEDDoseFreq DAILY &0830 69620002 SNOMEDDoseFreq Q24HRS 396125000 SNOMEDDoseFreq ONE TIME ORDER 422114001 SNOMEDDoseUNIT Puff 415215001 SNOMEDDoseUNIT TABLET 428673006 SNOMEDDoseUNIT tsp 415703001 SNOMEDDoseUNIT CAPSULE (HA 415215001 SNOMEDDoseUNIT patch 419702001 SNOMEDDoseUNIT gr 258682000 SNOMEDDoseUNIT mL 258773002 SNOMED

Page 23: Part I: Introduction to SHARPn Normalization Hongfang Liu, PhD, Mayo Clinic Tom Oniki, PhD, Intermountain Healthcare

Pipeline

Implement in UIMA (Unstructured Information Management Architecture)

Configurable – Data sources – HL7, CCD, CDA, and Table format – Model mappings (different EMR systems may have

different formats)– Terminology mappings– Inference mappings – infer ingredients from clinical

drugs